Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Study may help refocus research efforts on adolescent and young adult cancer survivorship

Study may help refocus research efforts on adolescent and young adult cancer survivorship

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

Oral targeted therapy found to be an effective treatment option for high-risk hairy cell leukemia

MET amplification identified as a potentially actionable driver for non-small cell lung cancer

MET amplification identified as a potentially actionable driver for non-small cell lung cancer

Research team identifies a way to improve immune response during viral infections

Research team identifies a way to improve immune response during viral infections

NYU Abu Dhabi researchers use NMR spectroscopy to map the structure of specific nanobody

NYU Abu Dhabi researchers use NMR spectroscopy to map the structure of specific nanobody

COVID-19 vaccines are effective in 94% of cancer patients, shows study

COVID-19 vaccines are effective in 94% of cancer patients, shows study

RESILIENCE project aims to reduce the burden of cardiovascular disease in cancer survivors

RESILIENCE project aims to reduce the burden of cardiovascular disease in cancer survivors

FDA approves alternative component of chemotherapy regimen to treat acute lymphoblastic leukemia

FDA approves alternative component of chemotherapy regimen to treat acute lymphoblastic leukemia

Maternal Omega 3-rich diet may reduce onset of breast cancer in offspring

Maternal Omega 3-rich diet may reduce onset of breast cancer in offspring

New blood test can accurately detect 50 types of cancer before symptoms emerge

New blood test can accurately detect 50 types of cancer before symptoms emerge

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Smoother silicone breast implants can reduce inflammation and other immune system reactions

Smoother silicone breast implants can reduce inflammation and other immune system reactions

Researchers analyze how breast implant surfaces influence immune response

Researchers analyze how breast implant surfaces influence immune response

New breakthrough could lead to a cure for common childhood cancer

New breakthrough could lead to a cure for common childhood cancer

New research uncovers substantial differences in rates of childhood cancers

New research uncovers substantial differences in rates of childhood cancers

Convalescent plasma associated with better survival in blood cancer patients with COVID-19

Convalescent plasma associated with better survival in blood cancer patients with COVID-19

Convalescent plasma can improve chances of survival among blood cancer patients with COVID-19

Convalescent plasma can improve chances of survival among blood cancer patients with COVID-19

Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting

Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting

UC San Diego Health offers new immunotherapy treatment for multiple myeloma following FDA approval

UC San Diego Health offers new immunotherapy treatment for multiple myeloma following FDA approval